PCR and Real-time PCR Molecular Diagnostics Market 2022- By Offering, By Farm Type, By Livestock Type, By Application & Global Region - Market Size, Trends, Opportunity, Forecast 2027
Life ScienceRequest PDF Sample Request Free Customization
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the PCR and Real-time PCR Molecular Diagnostics MarketRequest Sample
The real-time polymerase chain reaction is a molecular diagnostic testing technique used for the identification of the genetic sequence of DNA or RNA is present or not in the given sample. This technique is used to amplify or make more replicas of the genetic material through a series of heating and cooling cycles. This is then further identified by the laboratory equipment and if the amplification is shown means the bacteria, virus, or cancer gene was present in the sample then the result is considered as positive, and if not means it is not present which implies a negative result. This method gives a higher degree of accuracy than microscopy. So, due to the accuracy level provided by real-time PCR, the demand is increasing in the market.
The effectiveness of the real-time PCR molecular diagnostic is the driving factor for market growth. The PCR and real-time PCR molecular diagnostics provide a greater accuracy level as compared to the other process. It is very difficult to make decisions when the result is not accurate. It’s the question of the life and death of the patient. In 2018, globally Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are one of the leading causes of chronic liver diseases. As per the research, the World Health Organization declared that more than 250 million people are infected with HBV and more than 70 million with HCV. Around 1.34 million people died due to the Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections globally in 2015. These numbers are high as compared to the number of deaths by HIV. Due to such factors, the concern towards the health of the people globally is rising and the focus of the health organizations is towards the accuracy in the treatment of these diseases and making this count lesser. These factors are spurring the PCR and Real-time PCR molecular diagnostics market in the forecast period.
Globally every day around 1 million sexually transmitted infections (STIs) are acquired. Every year it is estimated that 376 million new infections with 1 of 4 STIs are chlamydia (127 million) gonorrhea (87 million), syphilis (6.3 million), and trichomoniasis (156 million) are happening. Additionally, it is estimated that 65 million people have moderate to severe chronic obstructive pulmonary disease (COPD), from which about 3 million die each year, making it the third leading cause of death globally and the numbers are increasing. More than 334 million crowds suffer from asthma, more affected chronic disease in childhood, affecting 14% of children globally. The prevalence of asthma in children is rising. Such figures show that the need for PCR and real-time PCR molecular diagnostics in the market. The increasing use of such technologies for infectious diseases testing like HCV and HBV, Sexually Transmitted Infections, Hospital Acquired Infection, Respiratory Infections, and Oncology Testing, Genetic Testing and other application is propelling the market growth in the near future.
The further driving factor in the market is the Covid-19 pandemic. The rising cases in the various regions will increase the demand for the RT-PCR tests in the market.
In terms of applications, infectious diseases are taking more percentages in the market due to the increasing number of sexually transmitted infections, respiratory infections, and hepatitis C and B. Till 2026, it is estimated that consumables and reagents are primary PCR products. Based on end-use industries, hospitals are the most dominating segment in terms of revenue in the market due to the rising complicated tests and availability of the capable person. The companies are focussing on the new product development to fits the consumer demand so, the Academic and Research Centres will show a significant market share in the PCR and Real-time PCR Molecular Diagnostics Market.
PCR and Real-time PCR Molecular Diagnostics Market Segmentation
- Traditional PCR
- Real-time PCR
- Digital PCR
- Infectious Diseases Testing
- HCV and HBV
- Sexually Transmitted Infections
- Hospital Acquired Infection
- Respiratory Infections
- Oncology Testing
- Genetic Testing
By End User
- Diagnostic Laboratories
- Academic and Research Centres
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
North America is the most prominent region in the PCR and real-time PCR molecular diagnostics market due to the new technological development processes and growing healthcare industry in U.S., Canada, and Mexico. These factors will create new opportunities for new entrants in the North American market. Further, the regulation given by FDA will proliferate the market growth in the forecast period.
Asia pacific is having the second-largest share in the PCR and real-time PCR molecular diagnostics market. Some figures show that 97% of the deaths are due to viral hepatitis in the Western Pacific region. Such factors in the other regions will also fuel the product demand in the near future.
Few Key Players in the PCR and Real-time PCR Molecular Diagnostics Market
- Abbott Laboratories
- BioMerieux SA
- Danaher Corporation
- Bio-Rad Laboratories
- Becton, Dickinson and Company
- QIAGEN N.V
- F-Hoffmann-La Roche Ltd.
- Genomic Health
- GRIFOLS S.A
- Thermo Fisher Scientific Inc.
- Seegene Inc.
- Hologic Inc.
- Other Players
Powered by Froala Editor
Powered by Froala Editor
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.